Treatment and follow-up of clinical cyathostominosis in horses.

The research involved studying the effects of moxidectin and ivermectin on treating cyathostominosis in horses. The treatment was successful in eliminating larvae but did not significantly improve the horses’ body weight or clinical conditions over a three-week period.

Objective of the Study

• The primary aim of this research was to examine the effectiveness of moxidectin or ivermectin in treating horses diagnosed with clinical cyathostominosis. The research focused on observing any changes in the condition of the horses within a span of 3 weeks following the treatment.

Methodology and Results of the Study

• The research involved 20 horses that were confirmed to have clinical cyathostominosis. These horses were treated with either moxidectin or ivermectin.
• Throughout a three-week observation period, it was determined that both treatments were efficacious in completely eliminating cyathostomin eggs from the horses’ feces within about 1 or 2 weeks.
• Despite the successful eradication of the larvae from the horses, there wasn’t a significant improvement in the body weight or any other clinical parameters of the horses throughout the observation period.
• This means that while both moxidectin and ivermectin are successful in eliminating the cyathostomin larvae, they do not directly contribute significantly to the overall health improvement of the treated horses within the short observation period of 3 weeks.

Conclusion and Implications

• The researchers concluded that despite the treatments’ success in eliminating larvae, the short-term results of the treatment were not satisfactory in terms of body weight gain and improvement in clinical parameters.
• Given these results, the study underscores the importance of preventing cyathostominosis in horses rather than just focusing on treatment. The researchers suggest further studies and efforts should focus more on cyathostominosis prevention measures to reduce its prevalence.